“Scarf Lady” Dr. Deborah Birx is Now the New CEO of a Clinical-Stage Biotechnology Company
Source: Armata Pharmaceuticals
Scarf Lady should be in jail.
Armata Pharmaceuticals, Inc. announced last week that former White House COVID-19 response coordinator Dr. Deborah Birx has been appointed as its new Chief Executive Officer.
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology.
Dr. Birx, who succeeded Dr. Brian Varnum on July 10, 2023, will also be joining the company’s Board of Directors.
“I am thrilled to join Armata at this pivotal time in the Company’s development,” said Dr. Birx in her first statement as Armata’s new CEO.
“I’m impressed with the scientific platform’s quality and the team’s commitment to introducing innovative treatment options for patients suffering from serious bacterial infections.
